Skip to main content
Year archive

GenFleet Therapeutics (Shanghai) Inc. — 2022 filings

All 34 regulatory filings released by GenFleet Therapeutics (Shanghai) Inc. (2595) in 2022, sourced directly from the official regulator.

34 Filings
2022 Period
2022 filings (34)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Share Issue/Capital Change
2022-12-30 English
Final Dividend for the year ended 30th September, 2022
Notice of Dividend Amount
2022-12-16 English
Final Results Announcement for the Year Ended 30th September, 2022
Annual Report FY 2022
2022-12-16 English
Proposed Adoption of the Amended and Restated Memorandum and Articles of Association
Governance Information
2022-12-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-11-30 English
Date of Board Meeting
Report Publication Announcement
2022-11-28 English
Profit Warning
Regulatory Filings
2022-11-23 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-10-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-09-30 English
Appointment of Independent Non-Executive Director and Members of Board Committees
Board/Management Information
2022-09-05 English
List of Directors and their Role and Function
Board/Management Information
2022-09-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-08-31 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-07-29 English
Supplemental Announcement - Settlement Deed Relating to Acquisition of a Beauty Company
Capital/Financing Update
2022-07-28 English
Change of Address of Hong Kong Branch Share Registrar and Transfer Office
Regulatory Filings
2022-07-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-06-30 English
Settlement Deed relating to Acquisition of a Beauty Company
M&A Activity
2022-06-23 English
Interim Report 2022
Interim / Quarterly Report H1 2022
2022-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-05-31 English
Interim Results Announcement for the Six Months Ended 31st March, 2022
Interim / Quarterly Report H1 2022
2022-05-27 English
Date of Board Meeting
Report Publication Announcement
2022-05-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-04-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-03-31 English
Poll Results of the Rescheduled Annual General Meeting Held on 18 March 2022
Declaration of Voting Results & Voting Rights Announcements
2022-03-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-02-28 English
Rescheduled Payment Date of Final Dividend for the year ended 30 September 2021
Notice of Dividend Amount
2022-02-25 English
Rescheduled Annual General Meeting and Special Arrangements
AGM Information
2022-02-25 English
Change of Final Dividend Payment Date
Notice of Dividend Amount
2022-02-14 English
Postponement of Annual General Meeting, Change of Book Closure Periods and Final Dividend Payment Date
Regulatory Filings
2022-02-14 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-01-31 English
Notice of Annual General Meeting
AGM Information
2022-01-13 English
Form of Proxy for the Annual General Meeting to be held on 18 February 2022
AGM Information
2022-01-13 English
(1) Renewal of General Mandates to Issue New Shares and Repurchase Shares&#x3b; (2) Re-election of Retiring Directors&#x3b; and (3) Notice of Annual General Meeting
AGM Information
2022-01-13 English
Annual Report 2021
Annual Report FY 2021
2022-01-13 English